Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

Prevention and treatment of cardiovascular disorders by HMG-CoA reductase inhibitors (or statins), beyond their lipid-lowering properties, have been demonstrated including activation of the endothelial nitric oxide synthase (eNOS). Beside endothelial cells, red blood cells (RBCs) possess NOS and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludolph, Barbara, Bloch, Wilhelm, Kelm, Malte, Schulz, Rainer, Kleinbongard, Petra
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350149/
https://www.ncbi.nlm.nih.gov/pubmed/18200826

Ejemplares similares

Ejemplares similares